头颈癌亚专科门诊姑息医学诊所的初步实践
该研究回顾性分析了2023年7月至2025年3月转诊至由头颈外科医生主导的新型头颈癌姑息治疗门诊的142例患者。多数患者为不可治愈疾病(73.9%),随访时ESAS-r气短、疲乏及GAD-7、PHQ-9评分显著改善,40.1%患者死亡,其中84.2%死于家中或临终关怀机构。手术和≥3次姑息治疗访视是生存的独立预后指标。
要点
- 头颈癌姑息治疗门诊可改善患者症状评分及焦虑抑郁评分。
- 手术和≥3次姑息治疗访视与生存改善独立相关。
- 多数死亡发生在家中或临终关怀机构,但激进终末期治疗仍常见。
核心结论
- 由头颈外科医生主导的亚专科姑息治疗门诊可观察到症状评分纵向改善、接受纵向姑息治疗者生存改善及高比例居家或临终关怀机构死亡。
研究设计与样本
- 回顾性综述2023年7月至2025年3月转诊至新型亚专科头颈癌姑息治疗门诊的142例患者。
主要发现
- 73.9%患者为不可治愈疾病,随访时ESAS-r气短、ESAS-r疲乏、GAD-7和PHQ-9评分显著改善。
- 死亡率为40.1%,84.2%的死亡发生在家中或临终关怀机构。
- 57.9%患者接受激进终末期治疗,其与继续抗癌治疗(79.4% vs. 26.1%)、较低临终关怀使用(55.9% vs. 82.6%)及急性护理机构死亡(27.3% vs. 0%)相关。
- 姑息性免疫治疗与临终关怀持续时间缩短相关(中位15天[IQR=4-63]),优于其他抗癌治疗(中位27天[23-63])或支持治疗(中位68天[26-162])。
- 多变量分析中,手术(HR=0.08 [95%CI=0.01-0.39])和≥3次姑息治疗访视(HR=0.24 [0.08-0.73])是生存的独立预后指标。
临床怎么用
- 头颈癌患者可从亚专科姑息治疗门诊中获益,应关注症状评估及纵向随访。
- 早期整合姑息治疗可能减少激进终末期治疗并提高居家或临终关怀机构死亡比例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Head and neck cancer (HNC) patients have high palliative care (PC) needs. We reviewed our initial experience with a novel subspecialty HNC outpatient PC clinic, led by a Hospice and Palliative Medicine fellowship-trained HNC surgeon. METHODS: We retrospectively reviewed 142 patients referred to a novel subspecialty HNC PC clinic between July 2023 and March 2025. Symptom evaluation included the revised Edmonton Symptom Assessment System (ESAS-r), Patient Health Questionnaire-9 (PHQ-9) for Depression, Generalized Anxiety Disorder-7 (GAD-7), and frailty. Data were analyzed using cross-tabulations, multivariable linear regression, and multivariable survival analysis. RESULTS: Most patients had incurable disease (73.9%), with significant improvement in ESAS-r shortness of breath, ESAS-r tiredness, GAD-7, and PHQ-9 scores at follow-up. Mortality was 40.1%, and 84.2% of deaths occurred at home or in hospice. Aggressive end-of-life care occurred in 57.9% of patients and was associated with continued cancer-directed treatment (79.4% vs. 26.1%), lower hospice use (55.9% vs. 82.6%), and death in an acute-care facility (27.3% vs. 0%). Palliative immunotherapy was associated with reduced hospice duration (median = 15 days [IQR = 4-63]) compared to other cancer-directed treatment (median = 27 days [23-63]) or supportive care (median = 68 days [26-162]). On multivariable analysis, surgery (HR = 0.08 [95% CI = 0.01-0.39]) and ≥ 3 PC visits (HR = 0.24 [0.08-0.73]) were independent prognostic indicators of survival. CONCLUSIONS: Patients seen in a surgeon-led subspecialty HNC PC clinic demonstrated observed longitudinal improvement in symptom scores, improved survival in patients receiving longitudinal PC, and a high rate of home or hospice deaths. These data suggest that subspecialist HNC PC adds value to multidisciplinary HNC care.
引用
- Gourin CG, Fakhry C, London NR, et al. Implementation of a Novel Subspecialty Outpatient Palliative Medicine Head and Neck Cancer Clinic. Laryngoscope. 2026. PMID: 42647137. doi:10.1002/lary.70863
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。